Senior Director, Biostatistics @ Neurogene Inc. | Jobright.ai
JOBSarrow
RecommendedLiked
0
Applied
0
Senior Director, Biostatistics jobs in New York, United States
Be an early applicantLess than 25 applicants
company-logo

Neurogene Inc. · 5 days ago

Senior Director, Biostatistics

Wonder how qualified you are to the job?

ftfMaximize your interview chances
Biotechnology

Insider Connection @Neurogene Inc.

Discover valuable connections within the company who might provide insights and potential referrals, giving your job application an inside edge.

Responsibilities

Serve as a lead statistician and manage statistical efforts for clinical studies
Contribute to clinical protocol development, including authoring sections on statistical methods and reviewing/editing other sections, by applying statistical principles
Author statistical analysis plans for studies and/or ISS/ISEs, and author/edit tables, figures, and listings
Review CRF designs to ensure data collection meets the study objectives and the requirements of statistical analyses
Provide statistical input to independent data monitoring board charters, project management plans, and other study-level documents
Work with statistical programmers or CROs to generate tables, figures, and listings
Support ongoing safety review and data monitoring review of the clinical development program/study teams
Perform ad hoc and exploratory statistical analyses as needed
Contribute to clinical study reports, including authoring of statistical sections and interpretation of the study results
Support regulatory submissions as needed
Support the preparation of publications, including manuscripts, posters, and oral presentations
Provide oversight of CROs for outsourced statistical activities and QC key results generated by CROs

Qualification

Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.

Clinical trial experiencePharmaceutical industry experienceClinical study designsProtocol draftingStatistical methodsPediatricsNeurologyRare diseasesGene therapyStatistical methods for clinical trialsFDA regulationsEMA regulationsICH guidelinesStatistical programmingSASRProject managementMetrics trackingProblem-solvingEffective communicationAnalyticalOrganizationalSelf-starterHigh energyInitiativeSelf-motivationFast-pacedSense of urgencyPassionateCollaborative

Required

PhD in biostatistics, mathematics, statistics, public health, or related discipline, with at least 7 years of relevant clinical trial experience
MS in biostatistics, mathematics, statistics, public health, or related discipline, with at least 9 years of relevant clinical trial experience
7-9 years of substantive experience in the pharmaceutical/biotechnology industry
In-depth understanding of clinical study designs, drafting protocols, authoring statistical methods sections in Regulatory documents
Experience in pediatrics, neurology, rare diseases and/or gene therapy and small trial designs would be ideal
Deep knowledge of statistical methods for clinical trials
Knowledge of FDA, EMA and ICH regulations and guidelines
Proficient in statistical programming (SAS is required and R is a plus)
Effective communication skills and ability to work with cross-functional study teams
Excellent analytical and problem-solving skills
Strong organizational skills and ability to deliver professional and quality work products, while working on multiple projects in an extremely fast-paced environment
Continuous strong focus on meeting or exceeding expectations in executing deliverables, performance and results.
Ability to track and measure performance against defined metrics.
Self-starter with high degree of energy, independence, initiative and self-motivation, as illustrated by the ability to instill a sense of pace and urgency into the team
Someone who moves fast and decisively in a balanced manner, with a passion for the growing company
Passionate, collaborative, creative, willing to take prudent risks, and motivated by the creation of a company focused on transformative treatments for patients and their families

Preferred

Experience with trial design software

Company

Neurogene Inc.

twittertwitter
company-logo
Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families.

Funding

Current Stage
Growth Stage
Total Funding
$183.5M
Key Investors
EcoR1 Capital
2020-12-16Series B· $115M
2019-02-12Series A· $68.5M

Leadership Team

leader-logo
Rachel McMinn
Founder, President, & CEO
linkedin
leader-logo
Julie Choi Jordan
Chief Medical Officer
linkedin
Company data provided by crunchbase
logo

Orion

Your AI Copilot